| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/12/2023 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Options to purchase common stock | 50k | $0.79 | $39.5k | | 05/12/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Common Stock | 5.8k | $20.00 | $116k | | 03/02/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Common Stock | 2k | $20.00 | $40k | | 03/02/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Stock Option (right to buy) | 2.5k | $12.75 | $31.9k | | 03/02/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Stock Option (right to buy) | 2.5k | $13.30 | $33.2k | | 03/02/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Stock Option (right to buy) | 5k | $15.56 | $77.8k | | 03/02/2023 |
| 03/02/2023 | OPIANT PHARMACEUTICALS, INC. | LLTP | Disposition | Common Stock | 2.5k | $8.79 | $22k | | 03/02/2023 |
| 12/27/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 15k | $18.59 | $278.8k | | 12/27/2022 |
| 12/27/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Restricted Stock Units | 4k | $0.00 | $0 | | 12/27/2022 |
| 12/06/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Restricted Stock Units | 1.3k | $0.00 | $0 | | 12/06/2022 |
| 08/24/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Options to purchase common stock | 40k | $2.53 | $101.2k | | 08/24/2022 |
| 06/14/2022 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Common Stock | 2k | $0.00 | $0 | | 06/14/2022 |
| 02/14/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Restricted Stock Units | 12k | $0.00 | $0 | | 02/14/2022 |
| 01/25/2022 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Options to purchase common stock | 50k | $3.35 | $167.5k | | 01/25/2022 |
| 12/28/2021 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 20k | $7.07 | $141.4k | | 12/28/2021 |
| 12/03/2021 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Restricted Stock Units | 1.3k | $0.00 | $0 | | 12/03/2021 |
| 06/15/2021 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Common Stock | 2k | $0.00 | $0 | | 06/15/2021 |
| 06/15/2021 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Stock Option (right to buy) | 2.5k | $13.30 | $33.2k | | 06/15/2021 |
| 12/30/2020 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 30k | $3.42 | $102.6k | | 12/30/2020 |
| 12/22/2020 | CATALYST PHARMACEUTICALS, INC. | CPRX | Exercise | Restricted Stock Units | 1.3k | $0.00 | $0 | | 12/22/2020 |
| 06/15/2020 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Common Stock | 2.5k | $8.79 | $22k | | 06/15/2020 |
| 06/15/2020 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Common Stock | 2k | $0.00 | $0 | | 06/15/2020 |
| 12/02/2019 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Restricted Stock Units | 4k | $0.00 | $0 | | 12/02/2019 |
| 12/02/2019 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 33.5k | $4.64 | $155.4k | | 12/02/2019 |
| 09/12/2019 | OPIANT PHARMACEUTICALS, INC. | LLTP | Purchase | Common Stock | 1.8k | $13.90 | $25k | | 09/12/2019 |
| 06/12/2019 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Stock Option (right to buy) | 2.5k | $12.75 | $31.9k | | 06/12/2019 |
| 12/19/2018 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 25k | $2.24 | $56k | | 12/19/2018 |
| 06/12/2018 | OPIANT PHARMACEUTICALS, INC. | LLTP | Grant | Stock Option (right to buy) | 5k | $15.56 | $77.8k | | 06/12/2018 |
| 01/02/2018 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 20k | $4.01 | $80.2k | | 01/02/2018 |
| 11/07/2017 | PALISADE BIO, INC. | CUR | Grant | | 100k | $1.12 | $112k | | 11/07/2017 |
| 06/28/2017 | SYNERGY PHARMACEUTICALS, INC. | SGYP | Grant | Stock Options | 62.5k | $4.50 | $281.2k | | 06/28/2017 |
| 01/25/2017 | PALISADE BIO, INC. | CUR | Purchase | | 2.8k | $3.52 | $10k | | 01/25/2017 |
| 01/03/2017 | CATALYST PHARMACEUTICALS, INC. | CPRX | Grant | Options to purchase common stock | 30k | $1.13 | $33.9k | | 01/03/2017 |
| 12/23/2016 | PALISADE BIO, INC. | CUR | Purchase | | 32.3k | $0.31 | $10k | | 12/23/2016 |
| 09/23/2016 | PALISADE BIO, INC. | CUR | Purchase | | 31.2k | $0.32 | $10k | | 09/23/2016 |
|